These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of common seric tumor markers in patients with solid cancers. Gara S; Boussen H; Ghanem A; Guemira F Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452 [TBL] [Abstract][Full Text] [Related]
3. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related]
4. [Biomarker in gynecologic malignancies]. Isonishi S Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576 [TBL] [Abstract][Full Text] [Related]
5. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma. Lopez JB; Balasegaram M; Timor J; Thambyrajah V Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242 [TBL] [Abstract][Full Text] [Related]
6. Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma. Uçkaya G; Ozet A; Arpaci A; Kömürcü S Nuklearmedizin; 1998; 37(8):297-8. PubMed ID: 9868713 [TBL] [Abstract][Full Text] [Related]
7. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer. Jiang XT; Tao HQ; Zou SC Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690 [TBL] [Abstract][Full Text] [Related]
8. [Limitation of clinical usefulness of tumor marker]. Ishii M Gan To Kagaku Ryoho; 1995 Aug; 22(9):1139-45. PubMed ID: 7544963 [TBL] [Abstract][Full Text] [Related]
9. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]. Ishii M Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347 [TBL] [Abstract][Full Text] [Related]
10. [Combined use of tumor markers and MRI tomography in differential diagnosis of ovarian neoplasms]. Pavlov SB; Akulina EA; Pavlova GB Klin Med (Mosk); 1999; 77(4):49-51. PubMed ID: 10356919 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic significance of tumor markers for gynecologic malignancies]. Aoki D; Hirasawa A; Susumu N Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829 [TBL] [Abstract][Full Text] [Related]
13. Serum tumor markers in patients on dialysis and kidney transplantation. Lye WC; Tambyah P; Leong SO; Lee EJ Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056 [TBL] [Abstract][Full Text] [Related]
14. Can we preoperatively risk stratify ovarian masses for malignancy? Oltmann SC; Garcia N; Barber R; Huang R; Hicks B; Fischer A J Pediatr Surg; 2010 Jan; 45(1):130-4. PubMed ID: 20105592 [TBL] [Abstract][Full Text] [Related]
15. [Tumor markers in cancer of the digestive system]. Zinser JW Rev Gastroenterol Mex; 1997; 62(3):145-8. PubMed ID: 9480520 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer. Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265 [TBL] [Abstract][Full Text] [Related]
17. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer]. Grotowski M Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers for the early detection of cancer: an inflammatory concept. Roy HK; Khandekar JD Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302 [No Abstract] [Full Text] [Related]
19. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]. Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303 [TBL] [Abstract][Full Text] [Related]
20. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency]. Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]